These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

359 related items for PubMed ID: 12458337

  • 21. Peripheral leukocytes with HLA-DR+/CD8- phenotype are associated with prognosis in patients with lung cancer.
    Nakamura H, Saji H, Aute I, Kawasaki N, Hosaka M, Ogata A, Saijo T, Kato H.
    Anticancer Res; 2003; 23(5b):4149-52. PubMed ID: 14666616
    [Abstract] [Full Text] [Related]

  • 22. Ran, a small GTPase gene, encodes cytotoxic T lymphocyte (CTL) epitopes capable of inducing HLA-A33-restricted and tumor-reactive CTLs in cancer patients.
    Azuma K, Sasada T, Takedatsu H, Shomura H, Koga M, Maeda Y, Yao A, Hirai T, Takabayashi A, Shichijo S, Itoh K.
    Clin Cancer Res; 2004 Oct 01; 10(19):6695-702. PubMed ID: 15475460
    [Abstract] [Full Text] [Related]

  • 23. The abnormal apoptosis of T cell subsets and possible involvement of IL-10 in systemic lupus erythematosus.
    Wang H, Xu J, Ji X, Yang X, Sun K, Liu X, Shen Y.
    Cell Immunol; 2005 Jun 01; 235(2):117-21. PubMed ID: 16226734
    [Abstract] [Full Text] [Related]

  • 24. The spontaneous CD8+ T-cell response to HLA-A2-restricted NY-ESO-1b peptide in hepatocellular carcinoma patients.
    Shang XY, Chen HS, Zhang HG, Pang XW, Qiao H, Peng JR, Qin LL, Fei R, Mei MH, Leng XS, Gnjatic S, Ritter G, Simpson AJ, Old LJ, Chen WF.
    Clin Cancer Res; 2004 Oct 15; 10(20):6946-55. PubMed ID: 15501973
    [Abstract] [Full Text] [Related]

  • 25. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
    Xue C, Lan-Lan W, Bei C, Jie C, Wei-Hua F.
    Cell Immunol; 2006 Feb 15; 239(2):121-8. PubMed ID: 16808908
    [Abstract] [Full Text] [Related]

  • 26. Antigen-specific CD8+ T lymphocytes generated from a DNA vaccine control tumors through the Fas-FasL pathway.
    Cheng WF, Lee CN, Chang MC, Su YN, Chen CA, Hsieh CY.
    Mol Ther; 2005 Nov 15; 12(5):960-8. PubMed ID: 15979942
    [Abstract] [Full Text] [Related]

  • 27. Recognition of HLA-A2-restricted mammaglobin-A-derived epitopes by CD8+ cytotoxic T lymphocytes from breast cancer patients.
    Jaramillo A, Narayanan K, Campbell LG, Benshoff ND, Lybarger L, Hansen TH, Fleming TP, Dietz JR, Mohanakumar T.
    Breast Cancer Res Treat; 2004 Nov 15; 88(1):29-41. PubMed ID: 15538043
    [Abstract] [Full Text] [Related]

  • 28. T-cell apoptosis and suppression of T-cell receptor/CD3-zeta by Fas ligand-containing membrane vesicles shed from ovarian tumors.
    Taylor DD, Gerçel-Taylor C, Lyons KS, Stanson J, Whiteside TL.
    Clin Cancer Res; 2003 Nov 01; 9(14):5113-9. PubMed ID: 14613988
    [Abstract] [Full Text] [Related]

  • 29. A dendritic cell-based tumour vaccine for lung cancer: full-length XAGE-1b protein-pulsed dendritic cells induce specific cytotoxic T lymphocytes in vitro.
    Zhou Q, Guo AL, Xu CR, An SJ, Wang Z, Yang SQ, Wu YL.
    Clin Exp Immunol; 2008 Sep 01; 153(3):392-400. PubMed ID: 18803763
    [Abstract] [Full Text] [Related]

  • 30. Naturally occurring T-cell response against mutated p21 ras oncoprotein in pancreatic cancer.
    Kubuschok B, Neumann F, Breit R, Sester M, Schormann C, Wagner C, Sester U, Hartmann F, Wagner M, Remberger K, Schilling M, Pfreundschuh M.
    Clin Cancer Res; 2006 Feb 15; 12(4):1365-72. PubMed ID: 16489095
    [Abstract] [Full Text] [Related]

  • 31. Identification of the HLA-Cw*0702-restricted tumor-associated antigen recognized by a CTL clone from a lung cancer patient.
    Nagata Y, Hanagiri T, Takenoyama M, Fukuyama T, Mizukami M, So T, Ichiki Y, Sugaya M, Sugio K, Yasumoto K.
    Clin Cancer Res; 2005 Jul 15; 11(14):5265-72. PubMed ID: 16033845
    [Abstract] [Full Text] [Related]

  • 32. A different pattern of cytotoxic T lymphocyte recognition against primary and metastatic tumor cells in a patient with nonsmall cell lung carcinoma.
    So T, Takenoyama M, Ichiki Y, Mizukami M, So T, Hanagiri T, Sugio K, Yasumoto K.
    Cancer; 2005 Jan 01; 103(1):200-8. PubMed ID: 15573370
    [Abstract] [Full Text] [Related]

  • 33. Serum DNase I, soluble Fas/FasL levels and cell surface Fas expression in patients with SLE: a possible explanation for the lack of efficacy of hrDNase I treatment.
    Tinazzi E, Puccetti A, Gerli R, Rigo A, Migliorini P, Simeoni S, Beri R, Dolcino M, Martinelli N, Corrocher R, Lunardi C.
    Int Immunol; 2009 Mar 01; 21(3):237-43. PubMed ID: 19181929
    [Abstract] [Full Text] [Related]

  • 34. Induction of immune responses and clinical efficacy in a phase II trial of IDM-2101, a 10-epitope cytotoxic T-lymphocyte vaccine, in metastatic non-small-cell lung cancer.
    Barve M, Bender J, Senzer N, Cunningham C, Greco FA, McCune D, Steis R, Khong H, Richards D, Stephenson J, Ganesa P, Nemunaitis J, Ishioka G, Pappen B, Nemunaitis M, Morse M, Mills B, Maples PB, Sherman J, Nemunaitis JJ.
    J Clin Oncol; 2008 Sep 20; 26(27):4418-25. PubMed ID: 18802154
    [Abstract] [Full Text] [Related]

  • 35. Dendritic cells fused with allogeneic colorectal cancer cell line present multiple colorectal cancer-specific antigens and induce antitumor immunity against autologous tumor cells.
    Koido S, Hara E, Homma S, Torii A, Toyama Y, Kawahara H, Watanabe M, Yanaga K, Fujise K, Tajiri H, Gong J, Toda G.
    Clin Cancer Res; 2005 Nov 01; 11(21):7891-900. PubMed ID: 16278414
    [Abstract] [Full Text] [Related]

  • 36. Spontaneous in vivo retrovirus-infected T and B cells, but not dendritic cells, mediate antigen-specific Fas ligand/Fas-dependent apoptosis of anti-retroviral CTL.
    Rich RF, Cook WJ, Green WR.
    Virology; 2006 Mar 15; 346(2):287-300. PubMed ID: 16337984
    [Abstract] [Full Text] [Related]

  • 37. Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma.
    Reichert TE, Strauss L, Wagner EM, Gooding W, Whiteside TL.
    Clin Cancer Res; 2002 Oct 15; 8(10):3137-45. PubMed ID: 12374681
    [Abstract] [Full Text] [Related]

  • 38. Aberrant expression and potency as a cancer immunotherapy target of inhibitor of apoptosis protein family, Livin/ML-IAP in lung cancer.
    Hariu H, Hirohashi Y, Torigoe T, Asanuma H, Hariu M, Tamura Y, Aketa K, Nabeta C, Nakanishi K, Kamiguchi K, Mano Y, Kitamura H, Kobayashi J, Tsukahara T, Shijubo N, Sato N.
    Clin Cancer Res; 2005 Feb 01; 11(3):1000-9. PubMed ID: 15709165
    [Abstract] [Full Text] [Related]

  • 39. Balanced regulation of mRNA production for Fas and Fas ligand in lymphocytes from centenarians: how the immune system starts its second century.
    Pinti M, Troiano L, Nasi M, Bellodi C, Ferraresi R, Mussi C, Salvioli G, Cossarizza A.
    Circulation; 2004 Nov 09; 110(19):3108-14. PubMed ID: 15505087
    [Abstract] [Full Text] [Related]

  • 40. Human monocyte-derived dendritic cells pulsed with wild-type p53 protein efficiently induce CTLs against p53 overexpressing human cancer cells.
    Tokunaga N, Murakami T, Endo Y, Nishizaki M, Kagawa S, Tanaka N, Fujiwara T.
    Clin Cancer Res; 2005 Feb 01; 11(3):1312-8. PubMed ID: 15709203
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.